Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2019-04-19 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于部分募集资金投资项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the delay of certain investment projects funded by proceeds from a non-public stock issuance. It details the original fundraising, the intended projects, the reasons for the delay, and approvals from the board, supervisory committee, independent directors, and the sponsoring institution. The document does not contain financial statements or detailed financial performance data but is a regulatory announcement about the status of capital use and project progress. It is not a full financial report, earnings release, or management discussion. The document is a formal disclosure related to capital use and project progress, fitting best under Capital/Financing Update (CAP). The document length is 3633 characters, which is relatively short but contains substantive information about capital investment project delays, not just a brief notice or report publication announcement. Therefore, the classification is CAP with high confidence.
2019-04-19 Chinese
第八届监事会第三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company, detailing the approval of various reports and proposals including the 2018 Supervisory Board Work Report, the 2018 Annual Report, the 2018 Financial Final Report, profit distribution plan, internal control evaluation report, and the 2019 Q1 report. It also includes voting results for these approvals. The document is not the reports themselves but a formal announcement of the Supervisory Board's resolutions and approvals regarding these reports and proposals. The document length is 3193 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a formal regulatory announcement of resolutions and approvals, not the full reports or detailed financial statements themselves.
2019-04-19 Chinese
2018年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled '2018年度监事会工作报告' which translates to '2018 Supervisory Board Work Report'. It details the activities and oversight performed by the supervisory board during 2018, including meetings held, review of financial reports (2017 annual report, 2018 quarterly and half-year reports), internal control evaluations, and audit opinions. The document is a comprehensive report on the supervisory board's work and opinions on company operations and financial management for the year 2018. It is not a full annual report itself but a supervisory board report related to the annual period. Given the nature of the document as a supervisory board work report, it fits best under the category of Audit Report / Information (AR), which includes audit reports and related supervisory information. The document length is 3806 characters, which is sufficient for a detailed report but not an announcement or brief notice. Therefore, the classification is AR with high confidence. FY 2018
2019-04-19 Chinese
董事会关于募集资金2018年度存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from the board of directors of 启迪古汉集团股份有限公司 regarding the use and management of funds raised through a non-public stock issuance in 2017, with specific financial figures and project updates through the end of 2018. It includes detailed tables on the amount raised, usage, bank accounts, investment projects, and compliance with regulatory requirements. The document is not a general annual report or earnings release but a specialized report focused on the use of raised capital. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital usage. The document length (7960 characters) and content confirm it is a full report, not just an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2019-04-19 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 年第一季度报告全文" which translates to "2019 First Quarter Report Full Text." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2019. The presence of quarterly financial statements and detailed financial analysis indicates this is a comprehensive interim financial report for a period shorter than a full fiscal year. There is no indication that this is an announcement or a brief summary; the document is lengthy (15,000 characters) and contains substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-19 Chinese
中德证券有限责任公司关于公司终止实施部分募集资金投资项目的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from the sponsor institution (中德证券有限责任公司) regarding the termination of part of the fundraising investment projects by 启迪古汉集团股份有限公司. It references regulatory guidelines related to fundraising management and usage, details the original fundraising amount, the projects planned, the reasons for termination of part of the projects, and the approval procedures undertaken. It is not a full financial report, earnings release, or management discussion, but rather a regulatory compliance and verification report related to fundraising projects. The document length is 2822 characters, which is relatively short but contains substantive content about the fundraising project termination and sponsor's opinion. This fits best under Capital/Financing Update (CAP) as it concerns updates on the use and changes in fundraising investment projects. It is not an announcement of a report publication, nor a general regulatory filing, but a specific update on capital usage and project termination related to fundraising.
2019-04-19 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.